title: Random anti-Müllerian hormone predicts ovarian response in women with high baseline follicle-stimulating hormone levels : anti-Müllerian hormone in poor responders in assisted reproductive treatment.
abstract: OBJECTIVE
  To evaluate the predictive value of random serum anti-Müllerian hormone (AMH) in the assessment of ovarian response in patients with diminished ovarian reserve (DOR; diagnosed after the observation of elevated baseline levels of early follicular follicle-stimulating hormone [FSH]) who were undergoing intracytoplasmic sperm injection-embryo transfer (ICSI-ET) and to compare the random serum AMH and baseline FSH levels in these patients for the prediction of poor ovarian response.
  
  
  METHODS
  Retrospective study.
  
  
  METHODS
  University hospital.
  
  
  METHODS
  One hundred and thirty-nine patients who were undergoing ICSI-ET cycles with early follicular FSH level >9 IU/mL.
  
  
  METHODS
  None.
  
  
  METHODS
  Poor ovarian response in ICSI-ET cycles.
  
  
  RESULTS
  For the identification of women at risk of cycle cancellation, an AMH cut-off level ≤1.2 ng/mL had 97.3 % sensitivity, 31.3 % specificity, 33.9 % positive predictive value, and 96.9 % negative predictive value in the women with high baseline FSH levels. An AMH cut-off level ≥1 ng/mL had a sensitivity of 58.7 % and specificity of 95.1 % for prediction of retrieval of 4 or more oocytes. By using a serum AMH cutoff level of 1.5 ng/mL, the ongoing pregnancies were predicted with 83.3 % sensitivity and 82.5 % specificity and yielded a positive predictive value of 31.2 % and a negative predictive value 98.1 %.
  
  
  CONCLUSIONS
  Measurement of random serum AMH level is a useful tool in the prediction of ovarian response in patients with high serum early follicular FSH levels.
authors.affiliation: Department of Obstetrics and Gynecology, IVF Center, School of Medicine, University of Ondokuz Mayıs, Kurupelit, Samsun, Turkey. drhandancelik@hotmail.com
authors.forename: Handan
authors.initials: H
authors.lastname: Celik
authors.forename: Devran
authors.initials: D
authors.lastname: Bıldırcın
authors.forename: Davut
authors.initials: D
authors.lastname: Güven
authors.forename: Mehmet B
authors.initials: MB
authors.lastname: Cetinkaya
authors.forename: Tayfun
authors.initials: T
authors.lastname: Alper
authors.forename: A Sertaç
authors.initials: AS
authors.lastname: Batuoğlu
mesh_terms: D000328:Adult; D054304:Anti-Mullerian Hormone / Q000097:blood*; D019540:Area Under Curve; D004624:Embryo Transfer / Q000379:methods*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007247:Infertility, Female / Q000628:therapy; D054315:Oocyte Retrieval / Q000379:methods; D010053:Ovary / Q000378:metabolism / Q000502:physiology*; D011237:Predictive Value of Tests; D011247:Pregnancy; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D020554:Sperm Injections, Intracytoplasmic / Q000379:methods*
chemical_list: D054304:Anti-Mullerian Hormone; D005640:Follicle Stimulating Hormone